Non-nicotinic transmission during ganglionic block with chlorisondamine and nicotine.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001338:Autonomic Fibers, Postganglionic / Q000502:physiology; D001339:Autonomic Fibers, Preganglionic / Q000502:physiology; D002415:Cats; D002714:Chlorisondamine / Q000494:pharmacology*; D004357:Drug Synergism; D004558:Electric Stimulation; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D008464:Mecamylamine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009538:Nicotine / Q000494:pharmacology*; D009541:Nictitating Membrane / Q000187:drug effects; D010830:Physostigmine / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects*; D013997:Time Factors
D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D011950:Receptors, Cholinergic; D008464:Mecamylamine; D009538:Nicotine; D001285:Atropine; D010830:Physostigmine; D002714:Chlorisondamine